Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease

References

• Mosmann T R, Coffman R L. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145–73
   PubMed Web of Science ®Google Scholar
• Gallin J L, Farber J M, Holland S M, Nutman T B. Interferon-y in the management of infectious diseases. Ann Intern Med 1995; 123: 216–24
   PubMed Web of Science ®Google Scholar
• Powrie F, Coffman R L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993; 14: 270–4
   PubMedGoogle Scholar
• Garside P, Mowat A M. Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defence. Immunol Today 1995; 16: 220–3
   PubMedGoogle Scholar
• Mosmann T R, Sad S. The expanding universe of T-cell subsets: Thl, Th2 and more. Immunol Today 1996; 17: 138–46
   PubMedGoogle Scholar
• Murphy T F, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146: 1067–83
   PubMed Web of Science ®Google Scholar
• Saikku P, Wang S P, Kleemola M, Brander E, Rusanen E, Grayston J T. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985; 151: 832–9
   PubMed Web of Science ®Google Scholar
• Storz J. Overview of animal diseases induced by chlamydial infections. Microbiology of Chlamydia, A L Barron. CRC Press, Boca Raton, FL 1988; 167–92
   Google Scholar
• Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992; 25(Suppl)27–34
   PubMedGoogle Scholar
• Schachter J. Overview of human diseases. Microbiology of Chlamydia, A L Barron. CRC Press, Boca Raton, FL 1988; 153–65
   Google Scholar
• Mårdh P A, Paavonen J, Puolakkainen M. Chlamydia. Plenum, New York 1989
   Google Scholar
• Holland M J, Bailey R L, Hayes L J, Whittle H C, Mabey D C. Conjunctival scarring in trachoma associated with depressed cell-mediated immune response to chlamydial antigens. J Infect Dis 1993; 168: 1528–31
   PubMed Web of Science ®Google Scholar
• Bcatty W L, Byrne G I, Morrison R P. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol 1994; 2: 94–8
   PubMedGoogle Scholar
• Ward M E. The immunobiology and immunopathology of chlamydial infections. APMIS 1995; 103: 769–96
   PubMed Web of Science ®Google Scholar
• Falsey A R, Walsh E E. Transmission of Chlamydia pneumoniae. J Infect Dis 1993; 168: 493–6
   PubMed Web of Science ®Google Scholar
• Aldous M B, Grayston J T, Wang S -P, Foy H M. Sero-epidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966–1979. J Infect Dis 1992; 166: 646–9
   PubMed Web of Science ®Google Scholar
• Ekman M -R, Grayston J T, Visakorpi R, Kleemola M, Kuo C -C, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993; 17: 420–5
   PubMed Web of Science ®Google Scholar
• Grayston J T. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992; 15: 757–63
   PubMed Web of Science ®Google Scholar
• Hyman C L, Roblin P M, Gaydos C A, Quinn T C, Schachter J, Hammerschlag M. Prevalence of asymptomatic nasopharyngeal carriage of Cblamaydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995; 20: 1174–8
   PubMed Web of Science ®Google Scholar
• Yang Z, Cummmings P K, Patton D L, Kuo C. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis 1994; 170: 464–7
   PubMed Web of Science ®Google Scholar
• Gaydos C A, Summersgill J T, Sahney N N, Ramirez J A, Quinn T C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996; 64: 1614–20
   PubMed Web of Science ®Google Scholar
• Kaukoranta-Tolvanen S -S, Laitinen K, Saikku P, Leinonen M. Chlamydial pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 1994; 16: 313–9
   PubMed Web of Science ®Google Scholar
• Godzik K L, O'Brien E R, Wang S -K, Kuo C -C. In vitro susceptibility of human vascular wall cells to infection wit Chlamydia pneumoniae. J Clin Microbiol 1995; 33: 2411–4
   PubMed Web of Science ®Google Scholar
• Yang Z, Kuo C, Grayston J T. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis 1995; 171: 736–8
   PubMed Web of Science ®Google Scholar
• Shor A, Kuo C C, Patton D L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82: 158–61
   PubMed Web of Science ®Google Scholar
• Kuo C C, Shor A, Campbell L A, Fukushi H, Patton D L, Grayston J T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841–9
   PubMed Web of Science ®Google Scholar
• Campbell L A, O'Brien E R, Cappuccio A L, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy. J Infect Dis 1995; 172: 585–8
   PubMed Web of Science ®Google Scholar
• Patton D L, Wolner-Hanssen P, Cosgrove S J, Holmes K K. The effects of Chlamydia trachomatis on the female reproductive tract of the Macaca nemestrina after a single tubal challence following repeated cervical inoculations. Obstet Gynecol 1990; 76: 643–50
   PubMed Web of Science ®Google Scholar
• Patton D L, Taylor H R. The histopathology of experimental trachoma: ultrastructural changes in the conjunctival epithelium. J Infect Dis 1986; 153: 870–8
   PubMed Web of Science ®Google Scholar
• Moulder J M. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991; 55: 143–90
   PubMedGoogle Scholar
• Byrne G I, Lehmann L K, Landry G J. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986; 53: 347–51
   PubMed Web of Science ®Google Scholar
• Summersgill J T, Sahney N N, Gaydos C A, Quinn T C, Ramirez J A. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 1995; 63: 2801–3
   PubMed Web of Science ®Google Scholar
• Kramer M J, Gordon F B. Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia. Infect Immun 1971; 3: 333–41
   PubMed Web of Science ®Google Scholar
• Beatty W L, Byrne G I, Morrison R P. Morphologic and antigenic characterization of interferon-gamma mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993; 90: 3998–4002
   PubMed Web of Science ®Google Scholar
• Grayston J T. Chlamydia pneumoniae, strain TWAR. Chest 1989; 95: 665–9
   Web of Science ®Google Scholar
• Grayston J T, Campbell L A, Kuo C -C, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618–25
   PubMed Web of Science ®Google Scholar
• Saikku P, Leinonen M, Manila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii: 983–6
   Web of Science ®Google Scholar
• Thorn D H, Wang S P, Grayston J T, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11: 547–51
   PubMedGoogle Scholar
• Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273–8
   PubMed Web of Science ®Google Scholar
• Thorn D H, Grayston J T, Siscovick D S, Wang S -P, Weiss N S, Daling J R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68–72
   PubMed Web of Science ®Google Scholar
• Linnanmaki E, Leinonen M, Mattila K, Nieminen M S, Valtonen V, Saikku P. Chlamydia pneumoniae-specif'ic circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130–4
   PubMed Web of Science ®Google Scholar
• Dahlen G H, Boman J, Birgander S L, Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995; 114: 165–74
   PubMed Web of Science ®Google Scholar
• Mendall M A, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995; 30: 121–8
   PubMed Web of Science ®Google Scholar
• Patel P, Mendall M A, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711–4
   PubMed Web of Science ®Google Scholar
• Ramirez J A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 1996; 125: 979–82
   PubMed Web of Science ®Google Scholar
• Kuo C C, Grayston J T, Campbell L A, Goo Y A, Wissler R W, Benditt E P. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc Natl Acad Sci USA 1995; 92: 6911–4
   PubMed Web of Science ®Google Scholar
• Melnick S L, Shahar E, Folsom A R, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993; 95: 499–504
   PubMed Web of Science ®Google Scholar
• Wimmer M LJ, Sandmann-Strupp R, Saikku P, Haberl R L. Association of chlamydial infection with cerebrovascular disease. Stroke 1996; 27: 2207–10
   PubMed Web of Science ®Google Scholar
• Ong G, Thomas B J, Mansfield A O, Davidson B R, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102–6
   PubMed Web of Science ®Google Scholar
• Juvonen J, Juvonen T, Laurila A, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997; 25: 499–505
   PubMed Web of Science ®Google Scholar
• Grönhagen-Riska C, Saikku P, Froseth B, Grayston T. Antibodies to TWAR - a novel type of Chlamydia - in sarcoidosis. Sarcoidosis and Other Granulomatous Disorders, C Grassi. Elsevier, Amsterdam 1988; 297–301
   Google Scholar
• Puolakkainen M, Campbell L A, Kuo C C, Leinonen M, Gronhagen-Riska C, Saikku P. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect 1996; 33: 199–205
   PubMed Web of Science ®Google Scholar
• Saario R, Toivanen A. Chlamydia pneumoniae as a cause of reactive arthritis. Br J Rheumatol 1994; 33: 1112
   PubMedGoogle Scholar
• Gran J T, Hjetland R, Andreassen A H. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae. Scand J Rheumatol 1993; 22: 43–4
   PubMed Web of Science ®Google Scholar
• Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994; 53: 100–5
   PubMed Web of Science ®Google Scholar
• Hahn D L, Dodge R, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA 1991; 266: 225–30
   PubMed Web of Science ®Google Scholar
• Allegra L, Blasi F, Centanni S, et al. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur RespirJ 1994; 7: 2165–8
   PubMed Web of Science ®Google Scholar
• Emre U, Roblin P M, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 48: 727–32
   Google Scholar
• Cunningham A, Johnston S, Julious S, Sillis M, Ward M. (1994) The role of Chlamydia pneumoniae and other pathogens in acute episodes of asthma in children. Chlamydial Infections. Proceedings of the 8th International Symposium of Human Chlamydia Infections, ChantillyFrance, 1994, J Orfila, G I Byrne, M A Chernesky, et al. Societa Editrice Esculapio, Bologna, 408–83
   Google Scholar
• Hahn D L, Anttila T, Saikku P. Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect 1996; 117: 513–7
   PubMed Web of Science ®Google Scholar
• Blasi F, Legnani D, Lombardo V M, et al. Chlamydia pneumoniae infection in acute exacerbation of COPD. Eur Respir Dis 1993; 6: 12–22
   Web of Science ®Google Scholar
• von Hertzen L, Isoaho R, Leinonen M, et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 1996; 25: 658–64
   PubMed Web of Science ®Google Scholar
• von Hertzen L, Alakarppa H, Koskinen R, et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997; 118: 155–64
   PubMed Web of Science ®Google Scholar
• Laurila A L, Anttila T, Laara E, et al. Serological evidence of an association of chronic Chlamydia pneumoniae infection with lung cancer. Int J Cancer 1997; 74: 31–4
   PubMed Web of Science ®Google Scholar
• Igietseme J U, Ramsey K H, Magee D M, Williams D M, Kincy T J, Rank R G. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Thl lymphocyte clone. Reg Immunol 1993; 5: 317–24
   PubMedGoogle Scholar
• Ramsey K H, Rank R G. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 1991; 59: 925–31
   PubMed Web of Science ®Google Scholar
• Bailey R L, Holland M J, Whittle H C, Mabey D C. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative response to chlamydial antigens compared with those of persistently diseased controls. Infect Immun 1995; 63: 389–92
   PubMed Web of Science ®Google Scholar
• Surcel H M, Syrjala H, Leinonen M, Saikku P, Herva E. Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro. Infect Immun 1993; 61: 2196–9
   PubMed Web of Science ®Google Scholar
• Ramsey K H, Soderberg L S, Rank R G. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun 1988; 56: 1320–5
   Google Scholar
• Ward M E. (1996) An update on the immunology of chlamydial infection. Proceedings of the 3rd Meeting of European Society for Chlamydia Research, ViennaAustria, 1996, A Stary. Societa Editrice Esculapio, Bologna, 58–62
   Google Scholar
• Tomasi T B, Grey H M. Structure and function of immunoglobulin A. Prog Allergy 1972; 16: 81–213
   PubMedGoogle Scholar
• Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227–57
   PubMed Web of Science ®Google Scholar
• Kelso A. The Thl/Th2 paradigm lost. Immunol Today 1995; 16: 374–9
   PubMedGoogle Scholar
• Paul W E, Seder R A. Lymphocyte responses and cytokines. Cell 1994; 76: 241–51
   PubMed Web of Science ®Google Scholar
• Romagnani S. Induction of Thl and Th2 responses: a key role for the “natural” immune response. Immunol Today 1992; 13: 379–81
   PubMedGoogle Scholar
• Scott P, Scharton T. Interaction between the innate and the acquired immune system following infection of different mouse strains with Leishmania major. Ann N Y Acad Sci 1994; 730: 84–92
   PubMed Web of Science ®Google Scholar
• Ben-Sasson S Z, LeGros G, Conrad D H, Finkelman F D, Paul W E. Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete IL-4 and other lymphokines. Proc Natl Acad Sci USA 1990; 87: 1421–5
   PubMed Web of Science ®Google Scholar
• Scott P, Natovitz P, Coffman R L, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988; 168: 1675–84
   PubMed Web of Science ®Google Scholar
• Jackson R J, Staats H F, Xu-Amano J, et al. Oral vaccine models: multiple delivery system employing tetanus toxoid. Ann N Y Acad Sci 1994; 730: 217–34
   PubMed Web of Science ®Google Scholar
• Street N E, Mosmann T R. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEBJ 1991; 5: 171–7
   PubMed Web of Science ®Google Scholar
• Daynes R A, Araneo B A. The development of effective vaccine adjuvants employing natural regulators of T cell lymphokine production in vivo. Ann N Y Acad Sci 1994; 730: 144–61
   PubMed Web of Science ®Google Scholar
• Rook G A, Hernandez-Pando R H, Lightman S L. Hormones, peripherally activated prohormones and regulation of the Thl/Th2 balance. Immunol Today 1994; 15: 301–3
   PubMedGoogle Scholar
• Byron K A, Varigos G A, Wootton A M. IL-4 production is increased in cigarette smokers. Clin Exp Immunol 1994; 95: 333–6
   PubMed Web of Science ®Google Scholar
• Rook G A, Onyebujoh P, Stanford J L. Thl/Th2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV. Immunol Today 1993; 14: 568–9
   PubMedGoogle Scholar
• Kronborg G. Lipopolysaccharide (LPS), LPS-immuno-complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. APMIS 1995; 103(Suppl)5–30
   Google Scholar
• Rennick D, Davidson N, Berg D. Interleukin-10 gene knockout mice: a model of chronic inflammation. Clin Immunol Immunopatbol 1995; 76: S174–8
   Google Scholar
• Hart P H, Vitti G F, Burgess D R, Whitty G A, Piccoli D S, Hamilton J A. Potential anti-inflammatory effects of interleukin 4, suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989; 86: 3803–7
   PubMed Web of Science ®Google Scholar
• Taylor C E. Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. Infect Immun 1995; 63: 3241–4
   PubMed Web of Science ®Google Scholar
• Weksler M E. The thymus gland and aging. Ann Intern Med 1983; 98: 105–7
   PubMed Web of Science ®Google Scholar
• Song L, Kim Y H, Chopra R K, et al. Age-related effects in T cell activation and proliferation. Exp Gerontol 1993; 28: 313–21
   Google Scholar
• Gillis S, Kozak R, Durante M, Weksler M E. Immunologicala studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981; 67: 937–42
   PubMed Web of Science ®Google Scholar
• Chopra R K, Holbrook N J, Powers D C, McCoy M T, Adler W H, Nagel J E. Interleukin 2, interleukin 2 receptor and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin Immunol Immunopatbol 1989; 53: 297–308
   PubMedGoogle Scholar
• Thoman M L, Weigle W O. Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol 1981; 127: 2101–6
   Web of Science ®Google Scholar
• Daynes R A, Araneo B A. Prevention and reversal of age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging Immunol Infect Dis 1992; 3: 135–54
   Google Scholar
• Hobbs M V, Weigle W O, Noonam D J, et al. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol 1993; 150: 3602–14
   PubMed Web of Science ®Google Scholar
• Orentreich N, Brind J L, Rizer R L, Vogclman J H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Clin Endocrinol Metab 1984; 59: 551–5
   Google Scholar
• Araneo B A, Woods M L, Daynes R A. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 1993; 167: 830–40
   PubMed Web of Science ®Google Scholar
• Daynes R A, Dudley D J, Araneo B A. Regulation of murine lymphokine production in vivo - 11. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 1990; 20: 793–802
   PubMed Web of Science ®Google Scholar
• Daynes R A, Meikle A W, Araneo B A. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 1991; 142: 40–5
   PubMedGoogle Scholar
• Jones J G, Minty B D, Lawler P, Hulands G, Crawley J C, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1980; i: 66–8
   Google Scholar
• Marcy T W, Merrill W W. Cigarette smoking and respiratory tract infection. Clin Chest Med 1987; 8: 381–91
   PubMed Web of Science ®Google Scholar
• Perkins R C, Griffith D E. Alterations in lung defense and unusual infections in chronic bronchitis. Semin Respir Infect 1994; 9: 41–8
   PubMedGoogle Scholar
• Laughter A H, Martin R R, Twomey J J. Lymphoproliferative responses to antigens mediated by human pulmonary alveolar macrophages. J Lab Clin Med 1977; 89: 1326–32
   PubMed Web of Science ®Google Scholar
• Schaberg T, Klein U, Raij M, Ellcr J, Lode H. Subpopulations of alveolar macrophages in smokers and nonsmokers: relation to the expression of CD11/CD18 molecules and superoxide anion production. Am J Respir Crit Care Med 1995; 151: 1551–8
   PubMed Web of Science ®Google Scholar
• Tollerud D J, Clark J W, Brown L M, et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989; 139: 194–8
   PubMed Web of Science ®Google Scholar
• Holt P. Immune and inflammatory function in cigarette smokers. Thorax 1987; 42: 241–9
   PubMed Web of Science ®Google Scholar
• Tollerud D J, Clark J W, Brown L M, et al. The effects of cigarette smoking on T cell subsets. Am Rev Respir Dis 1989; 139: 1446–51
   PubMed Web of Science ®Google Scholar
• Swain S L. IL-4 dictates T cell differentation. Res Immunol 1993; 144: 616–20
   PubMedGoogle Scholar
• Seder R A, Paul W E, Davis M M, Fazekas de St Groth B. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 1992; 176: 1091–8
   PubMed Web of Science ®Google Scholar
• Kaufmann S H. Immunity to intracellular microbial pathogens. Immunol Today 1995; 16: 338–42
   PubMedGoogle Scholar
• Oppenheim J J, Neta R. Pathophysiological roles of cytokines in development, immunity, and inflammation. EASEB J 1994; 8: 158–62
   Google Scholar
• von Hertzen L, Surccl H -M, Kaprio J, et al. Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking. J Med Microbiol, in press
   Web of Science ®Google Scholar
• Cupps T R, Fauci A S. Corticosteroid-mediated immuno-regulation in man. Immunol Rev 1982; 65: 133–55
   PubMed Web of Science ®Google Scholar
• Schleimer R P. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990; 141(Suppl)S59–69
   Google Scholar
• Boumpas D T, Chrousos G P, Wilder R L, Cupps T R, Balow J E. Glucocorticoid therapy for immune mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119: 1198–208
   PubMed Web of Science ®Google Scholar
• Bateman A, Singh A, Kral T, Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989; 10: 92–112
   PubMed Web of Science ®Google Scholar
• Daynes R A, Araneo B A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989; 19: 2319–25
   PubMed Web of Science ®Google Scholar
• Bertoglio J H, Leroux E. Differential effects of glucocorticoids on the proliferation of a murine helper and cytolytic T cell clone in response to IL-2 and IL-4. J Immunol 1988; 141: 1191–6
   PubMed Web of Science ®Google Scholar
• Wu C Y, Fargeas C, Nakajima T, Delespesse G. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur J Immunol 1991; 21: 2645–7
   PubMed Web of Science ®Google Scholar
• Zimmerman M J, Jewell D P. Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease. Aliment Pharmacol Tber 1996; 10(Suppl 2)93–8
   PubMedGoogle Scholar
• Wegmann T G, Lin H, Guilbert L, Mosmann T R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon. Immunol Today 1993; 14: 353–6
   PubMedGoogle Scholar
• Sheridan J F, Feng N G, Bonneau R H, Allen C M, Huncycutt B S, Glaser R. Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice. J Neuroimmunol 1991; 31: 245–55
   PubMed Web of Science ®Google Scholar
• Sturm D, Menzel J, Gottstein B, Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 1995; 63: 1688–97
   PubMed Web of Science ®Google Scholar
• Wilkins J N, Carlson H E, van Vunakis H, Hill M A, Gritz E, Jarvik M E. Nicotine from cigarette smoking increases circulating levels of Cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 1982; 78: 305–8
   PubMed Web of Science ®Google Scholar
• Winternitz W W, Quillcn D. Acute hormonal response to cigarette smoking. J Clin Pharmacol 1977; 17: 389–97
   PubMed Web of Science ®Google Scholar
• Mason D. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today 1991; 12: 57–60
   PubMedGoogle Scholar
• Grossman C J. Interactions between the gonadal steroids and the immune system. Science 1985; 227: 257–61
   PubMed Web of Science ®Google Scholar
• Paavonen T. Hormonal regulation of immune responses
   Google Scholar
• Heinzel F P, Sadick M D, Holaday B J, Coffman R L, Locksley R M. Reciprocal expression of interferon-gamma or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169: 59–72
   PubMed Web of Science ®Google Scholar
• Westendorp R G, Langermans J A, Huizinga T W, et al. Genetic influence on cytokine production and fatal menigococcal disease. Lancet 1997; 349: 170–3
   PubMed Web of Science ®Google Scholar
• Goldstein R A, Paul W E, Metcalfe D D, Busse W W, Reece E R. NIH conference. Asthma. Ann Intern Med 1994; 121: 698–708
   PubMedGoogle Scholar
• Hurd S. The lung health study. Eur Respir Rev 1991; 1: 415–9
   Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disase (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–43
   PubMed Web of Science ®Google Scholar
• Hoidal J R. Pathogenesis of chronic bronchitis. Semin Respir Infect 1994; 9: 8–12
   PubMedGoogle Scholar
• Fletcher C, Peto R. The natural history of chronic airway obstruction. BMJ 1977; 1: 1645–8
   PubMed Web of Science ®Google Scholar
• Higgins M. Risk factors associated with chronic obstructive lung disease. Ann N Y Acad Sci 1991; 624: 7–17
   PubMed Web of Science ®Google Scholar
• Cosio M G, Ghezzo H, Hogg J C, et al. The relationship between structural changes in small airways and pulmonary-function tests. Engl J Med 1978; 298: 1277–81
   PubMed Web of Science ®Google Scholar
• Snider G L. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis 1989; 140(Suppl)S3–8
   Google Scholar
• Peto R, Speizer F E, Cochrane A L, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128: 491–500
   PubMed Web of Science ®Google Scholar
• Lamb D. Pathology. Chronic Obstructive Pulmonary Disease, P Calverley, N Pride. Chapman and Hall, London 1995; 9–34
   Google Scholar
• Redline S, Weiss S T. Genetic and perinatal risk factors for the development of chronic obstructive pulmonary disease. Clinical Epidemiology of Chronic Obstructive Pulmonary Disease. Saunders NA, Hensley, MJ 1989; 139–68, New York: Marcel Dekker
   Google Scholar
• Burrows B. Airways obstructive diseases: pathogenetic mechanisms and natural histories of the disorders. Med Clin North Am 1990; 74: 547–59
   PubMed Web of Science ®Google Scholar
• Samet J M, Tager I B, Speizer F E. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am Rev Respir Dis 1983; 127: 508–23
   PubMed Web of Science ®Google Scholar
• Sunyer J, Saez M, Murillo C, Castellsague J, Martinez F, Anto J M. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. Am J Epidemiol 1993; 137: 701–5
   PubMed Web of Science ®Google Scholar
• Glindmeyer H W, Lefante J J, Jones R N, et al. Exposure-related declines in the lung function of cotton textile workers. Am Rev Respir Dis 1991; 144: 675–83
   PubMed Web of Science ®Google Scholar
• Griffith D E, Perkins R C. Changing strategies for treatment of chronic bronchitis. Semin Respir Infect 1994; 9: 49–57
   PubMedGoogle Scholar
• Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies W A, Hogg J C. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 148: 177–84
   Google Scholar
• Xu-Amano J, Beagley K W, Mega J, Fujihashi K, Kiyono K, McGhee J R. Induction of T helper cells and cytokines for mucosal IgA responses. Adv Exp Med Biol 1992; 327: 107–17
   PubMedGoogle Scholar
• Briere F, Bridon J M, Chevet D, et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994; 94: 97–104
   PubMed Web of Science ®Google Scholar
• Paavonen J. Genital Chlamydia trachomatis infections of the female. J Infect 1992; 25(Suppl 1)39–45
   PubMedGoogle Scholar